Related Experiment Video
Updated: Sep 1, 2025

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
Published on: January 19, 2024
Iron deficiency anemia and thrombosis risk in children-revisiting an old hypothesis
Hannah Kalff1, Holger Cario2, Susanne Holzhauer1
1Department of Pediatric Hematology and Oncology, Charité University Medicine, Berlin, Germany.
Insights
Iron deficiency anemia in children increases the risk of arterial and venous thrombosis. Understanding this link is crucial for effective treatment and prevention strategies in pediatric patients.
Area of Science:
- Pediatric Hematology
- Thrombosis Research
- Anemia Pathophysiology
Background:
- Iron deficiency anemia (IDA) is prevalent in children.
- IDA is a recognized risk factor for both arterial and venous thrombosis.
- Understanding the link between IDA and thrombosis is clinically significant due to available effective therapies.
Purpose of the Study:
- To summarize current evidence on the association between IDA and thrombosis.
- To raise awareness of iron deficiency as a pediatric thrombosis risk factor.
- To explore the translation of novel pathophysiological insights into clinical practice.
Main Methods:
- Review of current scientific literature and clinical data.
- Utilized an animal model of induced iron deficiency to investigate mechanisms.
- Analysis of pathophysiological pathways linking iron restriction to hypercoagulability.
Main Results:
- Iron deficiency anemia contributes to hypercoagulability.
- Identified multiple mechanisms by which IDA promotes thrombus formation and progression.
- Findings from animal models support conclusions drawn from clinical data.
Conclusions:
- Iron deficiency anemia is a significant risk factor for thrombosis in children.
- Novel pathophysiological concepts offer insights into clinical management.
- Further clinical studies are needed for prevention and treatment strategies in high-risk pediatric groups.
Abstract:
Iron deficiency anemia has a high prevalence in children and has repeatedly been implicated as a risk factor for arterial and venous thrombosis. As an effective therapy for iron deficiency anemia is available, understanding the association between this form of anemia and the potentially severe thrombosis phenotype is of major clinical interest. Recent findings shed light on pathophysiology of hypercoagulability resulting from iron-restricted erythropoiesis. Specifically, an animal model of induced iron deficiency allowed identifying multiple mechanisms, by which iron deficiency anemia results in increased thrombus formation and thrombus progression both in arterial and venous thrombosis. These findings complement and support conclusions derived from clinical data. The purpose of this mini review is to summarize current evidence on the association of iron deficiency anemia and thrombosis. We want to increase the awareness of iron deficiency as a risk factor for thrombosis in the pediatric population. We discuss how novel pathophysiological concepts can be translated into the clinical settings and suggest clinical studies on prevention and treatment strategies in high-risk patient groups.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Disorders of Erythrocytes
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Venous Thrombosis I: Introduction
Venous Thrombosis IV: Nursing Management
Factors Affecting Erythropoiesis
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...

